{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:20Z","timestamp":1792098560305,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472931"],"award-info":[{"award-number":["81472931"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872564"],"award-info":[{"award-number":["81872564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kashin-Beck disease (KBD) is an endemic osteoarthropathy, and its pathogenesis is still not entirely clear. Pathologically, many KBD changes are similar to those of osteoarthritis (OA). Therefore, this study aimed to identify changes in the levels of potential urinary biomarkers for OA, including C-telopeptide of type II collagen (uCTX-II), type II collagen cleavage neoepitope (uC2C), pyridinoline (uPYD), and uHelix-II, among adults with KBD.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Urinary samples of 83 external control (EC) subjects, 91 KBD patients, and 86 internal control (IC) subjects were tested by ELISA after the subjects completed a questionnaire and X-ray examination.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The medians of the four markers in the KBD group were higher than those in the EC group and those in the IC group. The medians in the grade II KBD group were higher than those in the grade I group but were not statistically significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.301, <jats:italic>P<\/jats:italic>\u2009=\u20090.408, <jats:italic>P<\/jats:italic>\u2009=\u20090.204, and <jats:italic>P<\/jats:italic>\u2009=\u20090.898 for uCTX-II, uC2C, uPYD, and uHelix-II, respectively). The area under the curve (AUC) of uCTX-II (0.775) was higher than that of the others (0.672, 0.639, and 0.628 for uC2C, uPYD, and uHelix-II, respectively).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The levels of uCTX-II, uC2C, uPYD, and uHelix-II were elevated in adults with KBD and showed an increasing trend as the severity of KBD increased. The prediction accuracy of uCTX-II was more useful than that of the others for assisting in the diagnosis of KBD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-019-1392-6","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T15:21:33Z","timestamp":1571671293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The urinary levels of CTX-II, C2C, PYD, and Helix-II increased among adults with KBD: a cross-sectional study"],"prefix":"10.1186","volume":"14","author":[{"given":"Quan Quan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Lu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Rui","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-4028","authenticated-orcid":false,"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.324_1378","volume":"324","author":"R Stone","year":"2009","unstructured":"Stone R. Diseases. A medical mystery in middle China. Science. 2009;324:1378\u201381. \n                    https:\/\/doi.org\/10.1126\/science.324_1378\n                    \n                  .","journal-title":"Science"},{"key":"1392_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00011-003-1177-5","volume":"52","author":"AJ Fosang","year":"2003","unstructured":"Fosang AJ, Stanton H, Little CB, et al. Neoepitopes as biomarkers of cartilage catabolism. Inflamm Res. 2003;52:277\u201382.","journal-title":"Inflamm Res"},{"key":"1392_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jim.2004.09.005","volume":"294","author":"AR Poole","year":"2004","unstructured":"Poole AR, Ionescu M, Fitzcharles MA, et al. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods. 2004;294:145\u201353. \n                    https:\/\/doi.org\/10.1016\/j.jim.2004.09.005\n                    \n                  .","journal-title":"J Immunol Methods"},{"key":"1392_CR4","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/oxfordjournals.jbchem.a133657","volume":"90","author":"A Uchiyama","year":"1981","unstructured":"Uchiyama A, Inoue T, Fujimoto D. Synthesis of pyridinoline during in vitro aging of bone collagen. J Biochem. 1981;90:1795\u20138. \n                    https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a133657\n                    \n                  .","journal-title":"J Biochem"},{"key":"1392_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/art.20930","volume":"52","author":"N Charni","year":"2005","unstructured":"Charni N, Juillet F, Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 2005;52:1081\u201390. \n                    https:\/\/doi.org\/10.1002\/art.20930\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1392_CR6","unstructured":"National Health and Family Planning Commission of People\u2019s Republic of China. Diagnosis of Kashin-Beck disease (WS\/T 207\u20132010). 2010. (In Chinese)."},{"key":"1392_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.berh.2014.02.002","volume":"28","author":"FW Roemer","year":"2014","unstructured":"Roemer FW, Eckstein F, Hayashi D, et al. The role of imaging in osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28:31\u201360. \n                    https:\/\/doi.org\/10.1016\/j.berh.2014.02.002\n                    \n                  .","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1392_CR8","first-page":"209","volume":"58","author":"E Kalai","year":"2012","unstructured":"Kalai E, Bahlous A, Charni N, et al. Increased urinary type II collagen C-telopeptide levels in Tunisian patients with knee osteoarthritis. Clin Lab. 2012;58:209\u201315.","journal-title":"Clin Lab"},{"key":"1392_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3967\/bes2017.050","volume":"30","author":"ZJ Zhao","year":"2017","unstructured":"Zhao ZJ, Pu GL, Zhan PZ, et al. Detection of the urinary biomarkers PYD, CTX-II, and DPD in patients with Kashin-Beck disease in the Qinghai province of China. Biomed Environ Sci. 2017;30:380\u20133. \n                    https:\/\/doi.org\/10.3967\/bes2017.050\n                    \n                  .","journal-title":"Biomed Environ Sci"},{"key":"1392_CR10","first-page":"517","volume":"20","author":"MY Jiang","year":"2014","unstructured":"Jiang MY, Tang JC, Xin LY. Detection of urine C2C level in patients with knee osteoarthritis. Chin J Osteopor. 2014;20:517\u201320 (In Chinese).","journal-title":"Chin J Osteopor"},{"key":"1392_CR11","first-page":"1027","volume":"23","author":"JM Halleen","year":"2003","unstructured":"Halleen JM. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Anticancer Res. 2003;23:1027\u20139.","journal-title":"Anticancer Res"},{"key":"1392_CR12","unstructured":"Que WJ, Feng ZP. Research progress of biochemical markers in bone conversion. Chin J Osteopor. 2014(5):575\u20139. (In Chinese)."},{"key":"1392_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/art.27202","volume":"62","author":"J Sarukawa","year":"2010","unstructured":"Sarukawa J, Takahashi M, Doi M, et al. A longitudinal analysis of urinary biochemical markers and bone mineral density in STR\/Ort mice as a model of spontaneous osteoarthritis. Arthritis Rheum. 2010;62:463\u201371. \n                    https:\/\/doi.org\/10.1002\/art.27202\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1392_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.0904-2512.2004.00097.x","volume":"33","author":"K Tanimoto","year":"2004","unstructured":"Tanimoto K, Ohno S, Imada M, et al. Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint. J Oral Pathol Med. 2004;33:218\u201323. \n                    https:\/\/doi.org\/10.1111\/j.0904-2512.2004.00097.x\n                    \n                  .","journal-title":"J Oral Pathol Med"},{"key":"1392_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/rheumatology\/35.11.1091","volume":"35","author":"MP Graverand","year":"1996","unstructured":"Graverand MP, Tron AM, Ichou M, et al. Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis. Br J Rheumatol. 1996;35:1091\u20135.","journal-title":"Br J Rheumatol"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3899\/jrheum.080642","volume":"36","author":"W Dong","year":"2009","unstructured":"Dong W, Zhang Y, Liu H, et al. Detection of unsaturated disaccharides, pyridinoline, and hydroxyproline in urine of patients with Kashin-Beck disease: comparison with controls in an endemic area. J Rheumatol. 2009;36:816\u201321. \n                    https:\/\/doi.org\/10.3899\/jrheum.080642\n                    \n                  .","journal-title":"J Rheumatol"},{"key":"1392_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/ard.2006.052621","volume":"65","author":"P Garnero","year":"2006","unstructured":"Garnero P, Charni N, Juillet F, et al. Increased urinary type II collagen helical and C-telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis. 2006;65:1639\u201344. \n                    https:\/\/doi.org\/10.1136\/ard.2006.052621\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"1392_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00296-011-2309-9","volume":"33","author":"X Wei","year":"2013","unstructured":"Wei X, Yin K, Li P, et al. Type II collagen fragment HELIX-II is a marker for early cartilage lesions but does not predict the progression of cartilage destruction in human knee joint synovial fluid. Rheumatol Int. 2013;33:1895\u20139. \n                    https:\/\/doi.org\/10.1007\/s00296-011-2309-9\n                    \n                  .","journal-title":"Rheumatol Int"},{"key":"1392_CR19","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/ar2596","volume":"11","author":"AC Bay-Jensen","year":"2009","unstructured":"Bay-Jensen AC, Tabassi NC, Sondergaard LV, et al. The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover. Arthritis Res Ther. 2009;11:R9.","journal-title":"Arthritis Res Ther"},{"key":"1392_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/01.WCB.0000121484.18437.98","volume":"11","author":"S Christgau","year":"2004","unstructured":"Christgau S, Tanko LB, Cloos PA, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause. 2004;11:508\u201318.","journal-title":"Menopause"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-019-1392-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-019-1392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:06:31Z","timestamp":1603148791000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-019-1392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1186\/s13018-019-1392-6","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Human Ethics Committee of the Endemic Disease Center of Harbin Medical University, People\u2019s Republic of China and the Administration Village Committee. Written informed consent was also obtained from the subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}